267 related articles for article (PubMed ID: 22615383)
1. Oncogene-mediated alterations in chromatin conformation.
Rickman DS; Soong TD; Moss B; Mosquera JM; Dlabal J; Terry S; MacDonald TY; Tripodi J; Bunting K; Najfeld V; Demichelis F; Melnick AM; Elemento O; Rubin MA
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9083-8. PubMed ID: 22615383
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer.
Elemento O; Rubin MA; Rickman DS
Cell Cycle; 2012 Sep; 11(18):3380-3. PubMed ID: 22918253
[TBL] [Abstract][Full Text] [Related]
3. COL11A2 collagen gene transcription is differentially regulated by EWS/ERG sarcoma fusion protein and wild-type ERG.
Matsui Y; Chansky HA; Barahmand-Pour F; Zielinska-Kwiatkowska A; Tsumaki N; Myoui A; Yoshikawa H; Yang L; Eyre DR
J Biol Chem; 2003 Mar; 278(13):11369-75. PubMed ID: 12554743
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription.
Patel M; Simon JM; Iglesia MD; Wu SB; McFadden AW; Lieb JD; Davis IJ
Genome Res; 2012 Feb; 22(2):259-70. PubMed ID: 22086061
[TBL] [Abstract][Full Text] [Related]
5. N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
Pflueger D; Rickman DS; Sboner A; Perner S; LaFargue CJ; Svensson MA; Moss BJ; Kitabayashi N; Pan Y; de la Taille A; Kuefer R; Tewari AK; Demichelis F; Chee MS; Gerstein MB; Rubin MA
Neoplasia; 2009 Aug; 11(8):804-11. PubMed ID: 19649210
[TBL] [Abstract][Full Text] [Related]
6. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.
Magistroni V; Mologni L; Sanselicio S; Reid JF; Redaelli S; Piazza R; Viltadi M; Bovo G; Strada G; Grasso M; Gariboldi M; Gambacorti-Passerini C
PLoS One; 2011; 6(11):e28162. PubMed ID: 22140532
[TBL] [Abstract][Full Text] [Related]
7. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
[TBL] [Abstract][Full Text] [Related]
8. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
[TBL] [Abstract][Full Text] [Related]
9. Microscopy-Based Chromosome Conformation Capture Enables Simultaneous Visualization of Genome Organization and Transcription in Intact Organisms.
Cardozo Gizzi AM; Cattoni DI; Fiche JB; Espinola SM; Gurgo J; Messina O; Houbron C; Ogiyama Y; Papadopoulos GL; Cavalli G; Lagha M; Nollmann M
Mol Cell; 2019 Apr; 74(1):212-222.e5. PubMed ID: 30795893
[TBL] [Abstract][Full Text] [Related]
10. Evf2 lncRNA/BRG1/DLX1 interactions reveal RNA-dependent inhibition of chromatin remodeling.
Cajigas I; Leib DE; Cochrane J; Luo H; Swyter KR; Chen S; Clark BS; Thompson J; Yates JR; Kingston RE; Kohtz JD
Development; 2015 Aug; 142(15):2641-52. PubMed ID: 26138476
[TBL] [Abstract][Full Text] [Related]
11. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
Zhang Y; Sif S; DeWille J
J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507
[TBL] [Abstract][Full Text] [Related]
12. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.
Martens JH; Mandoli A; Simmer F; Wierenga BJ; Saeed S; Singh AA; Altucci L; Vellenga E; Stunnenberg HG
Blood; 2012 Nov; 120(19):4038-48. PubMed ID: 22983443
[TBL] [Abstract][Full Text] [Related]
13. Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer.
Babu D; Fullwood MJ
Nat Genet; 2017 Aug; 49(9):1294-1295. PubMed ID: 28854182
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Mapping Targets of the Metazoan Chromatin Remodeling Factor NURF Reveals Nucleosome Remodeling at Enhancers, Core Promoters and Gene Insulators.
Kwon SY; Grisan V; Jang B; Herbert J; Badenhorst P
PLoS Genet; 2016 Apr; 12(4):e1005969. PubMed ID: 27046080
[TBL] [Abstract][Full Text] [Related]
15. YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion.
Rahim S; Beauchamp EM; Kong Y; Brown ML; Toretsky JA; Üren A
PLoS One; 2011 Apr; 6(4):e19343. PubMed ID: 21559405
[TBL] [Abstract][Full Text] [Related]
16. Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.
Visser M; Palstra RJ; Kayser M
Hum Mol Genet; 2015 May; 24(9):2649-61. PubMed ID: 25631878
[TBL] [Abstract][Full Text] [Related]
17. Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene.
Ribeiro FR; Paulo P; Costa VL; Barros-Silva JD; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
PLoS One; 2011; 6(7):e22317. PubMed ID: 21814574
[TBL] [Abstract][Full Text] [Related]
18. Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C).
Simonis M; Klous P; Splinter E; Moshkin Y; Willemsen R; de Wit E; van Steensel B; de Laat W
Nat Genet; 2006 Nov; 38(11):1348-54. PubMed ID: 17033623
[TBL] [Abstract][Full Text] [Related]
19. Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip.
Hoemme C; Peerzada A; Behre G; Wang Y; McClelland M; Nieselt K; Zschunke M; Disselhoff C; Agrawal S; Isken F; Tidow N; Berdel WE; Serve H; Müller-Tidow C
Blood; 2008 Mar; 111(5):2887-95. PubMed ID: 18024792
[TBL] [Abstract][Full Text] [Related]
20. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
Bailly RA; Bosselut R; Zucman J; Cormier F; Delattre O; Roussel M; Thomas G; Ghysdael J
Mol Cell Biol; 1994 May; 14(5):3230-41. PubMed ID: 8164678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
